NCT04577300View on ClinicalTrials.gov

Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

August 15, 2025

Study Completion Date

December 15, 2025

Conditions
Glaucoma
Interventions
DRUG

NT-501

Implant of Neurotech NT-501 device(s)

OTHER

Sham comparator

Sham implantation

Trial Locations (1)

94303

RECRUITING

Byers Eye Institute at Stanford University, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER